Luigi Mangione has abruptly withdrawn the psychiatric defense he planned to use at his upcoming trial for the killing of UnitedHealthcare CEO Brian Thompson, just one day after initially filing it in Manhattan Supreme Court.
Background
Mangione is accused of fatally shooting Thompson on a Midtown sidewalk in December 2024. The case has drawn national attention given the high-profile nature of both the victim and the accused. Mangione was apprehended weeks after the killing following an intense manhunt that spanned multiple states, with authorities recovering evidence including a ghost gun and journals allegedly detailing his grievances against the health insurance industry.
Prosecutors have built their case around physical evidence tying Mangione to the scene, including DNA matching and shell casings recovered at the shooting location. The defense had previously indicated they would pursue an aggressive strategy ahead of the September 8 trial date before Judge Gregory Carro in Manhattan Supreme Court.
The Defense Strategy
On Wednesday, defense attorneys filed notice with Judge Carro that they intended to raise an "extreme emotional disturbance" defense under CPL 250.10, a provision of New York criminal procedure law that allows defendants to argue mitigating circumstances at the time of an alleged crime. Such a defense, if accepted by jurors, could have reduced a second-degree murder charge to manslaughter.
However, in a letter obtained by the Post on Thursday, Mangione's lawyers wrote: "The defense respectfully withdraws CPL 250.10 notice at this time." The sudden reversal came just one day after Judge Carro revealed the psychiatric defense filing during court proceedings.
A spokesperson for Mangione's legal team declined to explain the rapid shift in strategy when contacted by the Post on Thursday.
Expert Analysis
Legal experts offered differing views on whether the withdrawn defense could have succeeded. Heather Cucolo, a criminal law professor at New York Law School, suggested jurors would struggle to accept an emotional disturbance claim given evidence that Mangione had meticulously planned the killing, including lying in wait outside Thompson's Midtown hotel before carrying out the shooting in daylight.
"A jury is going to have a difficult time with this," Cucolo told the Post, citing the deliberate nature of the alleged crime as a significant obstacle for any mental health defense.
Defense attorney Ron Kuby offered a contrasting perspective, describing the extreme emotional disturbance strategy as "sort of the perfect defense" because it would allow Mangione's attorneys to explore the healthcare system's role in his client's alleged psychological descent during trial proceedings.
Key Takeaways
- Luigi Mangione withdrew his CPL 250.10 notice just one day after filing it with Manhattan Supreme Court
- The extreme emotional disturbance defense could have potentially reduced murder charges to manslaughter if jurors accepted it
- Physical evidence including DNA and shell casings allegedly ties Mangione to the December 2024 shooting of CEO Brian Thompson
- Legal experts were divided on whether the psychiatric strategy would succeed given evidence of meticulous planning
What's Next
The case is scheduled to proceed to trial on September 8 in Manhattan Supreme Court before Judge Gregory Carro. Prosecutors have indicated they will pursue second-degree murder charges against Mangione. The defense's actual trial strategy remains unclear following the withdrawal of the psychiatric notice.